Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 159

1.
2.

Reliability and Validity of the 6-Minute Walk Test in Hypophosphatasia.

Phillips D, Tomazos IC, Moseley S, L'Italien G, Gomes da Silva H, Lerma Lara S.

JBMR Plus. 2019 Mar 1;3(6):e10131. doi: 10.1002/jbm4.10131. eCollection 2019 Jun.

3.

Natural History of Perinatal and Infantile Hypophosphatasia: A Retrospective Study.

Whyte MP, Leung E, Wilcox WR, Liese J, Argente J, Martos-Moreno GÁ, Reeves A, Fujita KP, Moseley S, Hofmann C; Study 011-10 Investigators.

J Pediatr. 2019 Jun;209:116-124.e4. doi: 10.1016/j.jpeds.2019.01.049. Epub 2019 Apr 9.

4.

Efficacy and Safety of Asfotase Alfa in Infants and Young Children With Hypophosphatasia: A Phase 2 Open-Label Study.

Hofmann CE, Harmatz P, Vockley J, Högler W, Nakayama H, Bishop N, Martos-Moreno GÁ, Moseley S, Fujita KP, Liese J, Rockman-Greenberg C; ENB-010-10 Study Group.

J Clin Endocrinol Metab. 2019 Jul 1;104(7):2735-2747. doi: 10.1210/jc.2018-02335.

5.

Impaired Spatial Reorientation in the 3xTg-AD Mouse Model of Alzheimer's Disease.

Stimmell AC, Baglietto-Vargas D, Moseley SC, Lapointe V, Thompson LM, LaFerla FM, McNaughton BL, Wilber AA.

Sci Rep. 2019 Feb 4;9(1):1311. doi: 10.1038/s41598-018-37151-z.

6.

Effects of two nights partial sleep deprivation on an evening submaximal weightlifting performance; are 1 h powernaps useful on the day of competition?

Brotherton EJ, Moseley SE, Langan-Evans C, Pullinger SA, Robertson CM, Burniston JG, Edwards BJ.

Chronobiol Int. 2019 Mar;36(3):407-426. doi: 10.1080/07420528.2018.1552702. Epub 2019 Jan 10.

PMID:
30626222
7.

Five-year efficacy and safety of asfotase alfa therapy for adults and adolescents with hypophosphatasia.

Kishnani PS, Rockman-Greenberg C, Rauch F, Bhatti MT, Moseley S, Denker AE, Watsky E, Whyte MP.

Bone. 2019 Apr;121:149-162. doi: 10.1016/j.bone.2018.12.011. Epub 2018 Dec 18.

8.

Asfotase alfa for infants and young children with hypophosphatasia: 7 year outcomes of a single-arm, open-label, phase 2 extension trial.

Whyte MP, Simmons JH, Moseley S, Fujita KP, Bishop N, Salman NJ, Taylor J, Phillips D, McGinn M, McAlister WH.

Lancet Diabetes Endocrinol. 2019 Feb;7(2):93-105. doi: 10.1016/S2213-8587(18)30307-3. Epub 2018 Dec 14.

9.

Validation of a Novel Scoring System for Changes in Skeletal Manifestations of Hypophosphatasia in Newborns, Infants, and Children: The Radiographic Global Impression of Change Scale.

Whyte MP, Fujita KP, Moseley S, Thompson DD, McAlister WH.

J Bone Miner Res. 2018 May;33(5):868-874. doi: 10.1002/jbmr.3377. Epub 2018 Feb 14.

10.

Perfecting the L5-S1 Spot Projection.

Moseley S.

Radiol Technol. 2016 Nov;88(2):216-217. No abstract available.

PMID:
27837137
11.

Asfotase alfa therapy for children with hypophosphatasia.

Whyte MP, Madson KL, Phillips D, Reeves AL, McAlister WH, Yakimoski A, Mack KE, Hamilton K, Kagan K, Fujita KP, Thompson DD, Moseley S, Odrljin T, Rockman-Greenberg C.

JCI Insight. 2016 Jun 16;1(9):e85971. doi: 10.1172/jci.insight.85971.

12.

Burden of disease in adult patients with hypophosphatasia: Results from two patient-reported surveys.

Weber TJ, Sawyer EK, Moseley S, Odrljin T, Kishnani PS.

Metabolism. 2016 Oct;65(10):1522-30. doi: 10.1016/j.metabol.2016.07.006. Epub 2016 Jul 19.

PMID:
27621187
13.

Fabrication and Characterization of Superconducting Resonators.

Cataldo G, Barrentine EM, Brown AD, Moseley SH, U-Yen K, Wollack EJ.

J Vis Exp. 2016 May 21;(111). doi: 10.3791/53868.

14.

Asfotase Alfa Treatment Improves Survival for Perinatal and Infantile Hypophosphatasia.

Whyte MP, Rockman-Greenberg C, Ozono K, Riese R, Moseley S, Melian A, Thompson DD, Bishop N, Hofmann C.

J Clin Endocrinol Metab. 2016 Jan;101(1):334-42. doi: 10.1210/jc.2015-3462. Epub 2015 Nov 3.

15.

Spatial Moran Models I. Stochastic Tunneling in the Neutral Case.

Durrett R, Moseley S.

Ann Appl Probab. 2015 Feb;25(1):104-115.

16.

Analysis and calibration techniques for superconducting resonators.

Cataldo G, Wollack EJ, Barrentine EM, Brown AD, Moseley SH, U-Yen K.

Rev Sci Instrum. 2015 Jan;86(1):013103. doi: 10.1063/1.4904972.

PMID:
25638068
17.

Astronomy. The other half of the universe?

Moseley SH.

Science. 2014 Nov 7;346(6210):696-7. doi: 10.1126/science.aaa1077. No abstract available.

PMID:
25378605
18.

A region of euchromatin coincides with an extensive tandem repeat on the mouse (Mus musculus) inactive X chromosome.

Darrow EM, Seberg AP, Das S, Figueroa DM, Sun Z, Moseley SC, Chadwick BP.

Chromosome Res. 2014 Sep;22(3):335-50. doi: 10.1007/s10577-014-9424-x. Epub 2014 May 13.

PMID:
24821208
19.

Micro-Spec: an ultracompact, high-sensitivity spectrometer for far-infrared and submillimeter astronomy.

Cataldo G, Hsieh WT, Huang WC, Moseley SH, Stevenson TR, Wollack EJ.

Appl Opt. 2014 Feb 20;53(6):1094-102. doi: 10.1364/AO.53.001094.

PMID:
24663307
20.

The macrosatellite DXZ4 mediates CTCF-dependent long-range intrachromosomal interactions on the human inactive X chromosome.

Horakova AH, Moseley SC, McLaughlin CR, Tremblay DC, Chadwick BP.

Hum Mol Genet. 2012 Oct 15;21(20):4367-77. Epub 2012 Jul 12.

21.

Molecular and biological characterization of Streptococcal SpyA-mediated ADP-ribosylation of intermediate filament protein vimentin.

Icenogle LM, Hengel SM, Coye LH, Streifel A, Collins CM, Goodlett DR, Moseley SL.

J Biol Chem. 2012 Jun 15;287(25):21481-91. doi: 10.1074/jbc.M112.370791. Epub 2012 May 1.

22.

Peripherally inserted central catheter usage patterns and associated symptomatic upper extremity venous thrombosis.

Liem TK, Yanit KE, Moseley SE, Landry GJ, Deloughery TG, Rumwell CA, Mitchell EL, Moneta GL.

J Vasc Surg. 2012 Mar;55(3):761-7. doi: 10.1016/j.jvs.2011.10.005.

23.

SpyA is a membrane-bound ADP-ribosyltransferase of Streptococcus pyogenes which modifies a streptococcal peptide, SpyB.

Korotkova N, Hoff JS, Becker DM, Quinn JK, Icenogle LM, Moseley SL.

Mol Microbiol. 2012 Mar;83(5):936-52. doi: 10.1111/j.1365-2958.2012.07979.x. Epub 2012 Jan 30.

24.

Properties of a variable-delay polarization modulator.

Chuss DT, Wollack EJ, Henry R, Hui H, Juarez AJ, Krejny M, Moseley SH, Novak G.

Appl Opt. 2012 Jan 10;51(2):197-208.

PMID:
22270517
25.

YY1 associates with the macrosatellite DXZ4 on the inactive X chromosome and binds with CTCF to a hypomethylated form in some male carcinomas.

Moseley SC, Rizkallah R, Tremblay DC, Anderson BR, Hurt MM, Chadwick BP.

Nucleic Acids Res. 2012 Feb;40(4):1596-608. doi: 10.1093/nar/gkr964. Epub 2011 Nov 7.

26.

Family history of dementia predicts worse neuropsychological functioning among HIV-infected persons.

Moore DJ, Arce M, Moseley S, McCutchan JA, Marquie-Beck J, Franklin DR, Vaida F, Achim CL, McArthur J, Morgello S, Simpson DM, Gelman BB, Collier AC, Marra CM, Clifford DB, Heaton RK, Grant I; Charter Group and HNRC Group.

J Neuropsychiatry Clin Neurosci. 2011 Summer;23(3):316-23. doi: 10.1176/appi.neuropsych.23.3.316.

27.

Duplex ultrasound screening detects high rates of deep vein thromboses in critically ill trauma patients.

Azarbal A, Rowell S, Lewis J, Urankar R, Moseley S, Landry G, Moneta G.

J Vasc Surg. 2011 Sep;54(3):743-7; discussion 747-8. doi: 10.1016/j.jvs.2011.02.058. Epub 2011 May 28.

28.

Variation in array size, monomer composition and expression of the macrosatellite DXZ4.

Tremblay DC, Moseley S, Chadwick BP.

PLoS One. 2011 Apr 22;6(4):e18969. doi: 10.1371/journal.pone.0018969.

29.

SpyA, a C3-like ADP-ribosyltransferase, contributes to virulence in a mouse subcutaneous model of Streptococcus pyogenes infection.

Hoff JS, DeWald M, Moseley SL, Collins CM, Voyich JM.

Infect Immun. 2011 Jun;79(6):2404-11. doi: 10.1128/IAI.01191-10. Epub 2011 Mar 21.

30.

Apical expression of human full-length hCEACAM1-4L protein renders the Madin Darby Canine Kidney cells responsive to lipopolysaccharide leading to TLR4-dependent Erk1/2 and p38 MAPK signalling.

Liévin-Le Moal V, Beau I, Rougeaux C, Kansau I, Fabrega S, Brice C, Korotkova N, Moseley SL, Servin AL.

Cell Microbiol. 2011 May;13(5):764-85. doi: 10.1111/j.1462-5822.2011.01575.x. Epub 2011 Feb 24.

PMID:
21352462
31.

Expression, tandem repeat copy number variation and stability of four macrosatellite arrays in the human genome.

Tremblay DC, Alexander G Jr, Moseley S, Chadwick BP.

BMC Genomics. 2010 Nov 15;11:632. doi: 10.1186/1471-2164-11-632.

32.

Symptomatic perioperative venous thromboembolism is a frequent complication in patients with a history of deep vein thrombosis.

Liem TK, Huynh TM, Moseley SE, Minjarez RC, Landry GJ, Mitchell EL, Deloughery TG, Moneta GL.

J Vasc Surg. 2010 Sep;52(3):651-7. doi: 10.1016/j.jvs.2010.04.029. Epub 2010 Jun 16.

33.

A multimodal imaging study in U.S. veterans of Operations Iraqi and Enduring Freedom with and without major depression after blast-related concussion.

Matthews SC, Strigo IA, Simmons AN, O'Connell RM, Reinhardt LE, Moseley SA.

Neuroimage. 2011 Jan;54 Suppl 1:S69-75. doi: 10.1016/j.neuroimage.2010.04.269. Epub 2010 May 6.

PMID:
20451622
34.

Modeling the intensity and polarization response of planar bolometric detectors.

Thomas CN, Withington S, Chuss DT, Wollack EJ, Moseley SH.

J Opt Soc Am A Opt Image Sci Vis. 2010 May 1;27(5):1219-31. doi: 10.1364/JOSAA.27.001219.

PMID:
20448791
35.

Evolution of resistance and progression to disease during clonal expansion of cancer.

Durrett R, Moseley S.

Theor Popul Biol. 2010 Feb;77(1):42-8. doi: 10.1016/j.tpb.2009.10.008. Epub 2009 Nov 5.

PMID:
19896491
36.

Negative regulation of Caenorhabditis elegans epidermal damage responses by death-associated protein kinase.

Tong A, Lynn G, Ngo V, Wong D, Moseley SL, Ewbank JJ, Goncharov A, Wu YC, Pujol N, Chisholm AD.

Proc Natl Acad Sci U S A. 2009 Feb 3;106(5):1457-61. doi: 10.1073/pnas.0809339106. Epub 2009 Jan 21.

37.

Practical protection.

Moseley S.

Nurs Stand. 2008 Oct 15-21;23(6):24-5.

PMID:
18988564
38.
39.

The Hertz/VPM polarimeter: design and first light observations.

Krejny M, Chuss D, d'Aubigny CD, Golish D, Houde M, Hui H, Kulesa C, Loewenstein RF, Moseley SH, Novak G, Voellmer G, Walker C, Wollack E.

Appl Opt. 2008 Aug 20;47(24):4429-40.

PMID:
18716650
40.

Clinical trials simulation: a statistical approach.

Westfall PH, Tsai K, Ogenstad S, Tomoiaga A, Moseley S, Lu Y.

J Biopharm Stat. 2008;18(4):611-30. doi: 10.1080/10543400802071303.

PMID:
18607794
41.

Escherichia coli DraE adhesin-associated bacterial internalization by epithelial cells is promoted independently by decay-accelerating factor and carcinoembryonic antigen-related cell adhesion molecule binding and does not require the DraD invasin.

Korotkova N, Yarova-Yarovaya Y, Tchesnokova V, Yazvenko N, Carl MA, Stapleton AE, Moseley SL.

Infect Immun. 2008 Sep;76(9):3869-80. doi: 10.1128/IAI.00427-08. Epub 2008 Jun 16.

42.

Limited use of the human patient simulator by nurse faculty: an intervention program designed to increase use.

King CJ, Moseley S, Hindenlang B, Kuritz P.

Int J Nurs Educ Scholarsh. 2008;5:Article12. doi: 10.2202/1548-923X.1546. Epub 2008 Mar 18.

PMID:
18384270
43.

Binding of Dr adhesins of Escherichia coli to carcinoembryonic antigen triggers receptor dissociation.

Korotkova N, Yang Y, Le Trong I, Cota E, Demeler B, Marchant J, Thomas WE, Stenkamp RE, Moseley SL, Matthews S.

Mol Microbiol. 2008 Jan;67(2):420-34. Epub 2007 Dec 11.

44.

Challenges, opportunities, and strategies--one program's experience with distance education: what we did and what we learned.

Moseley SK, Sakowski J.

J Health Adm Educ. 2001 Winter;19(1):71-87. No abstract available.

PMID:
17380646
45.

Selection for functional diversity drives accumulation of point mutations in Dr adhesins of Escherichia coli.

Korotkova N, Chattopadhyay S, Tabata TA, Beskhlebnaya V, Vigdorovich V, Kaiser BK, Strong RK, Dykhuizen DE, Sokurenko EV, Moseley SL.

Mol Microbiol. 2007 Apr;64(1):180-94.

46.

Expression of the Escherichia coli IrgA homolog adhesin is regulated by the ferric uptake regulation protein.

Rashid RA, Tarr PI, Moseley SL.

Microb Pathog. 2006 Dec;41(6):207-17. Epub 2006 Sep 6.

47.

A subfamily of Dr adhesins of Escherichia coli bind independently to decay-accelerating factor and the N-domain of carcinoembryonic antigen.

Korotkova N, Cota E, Lebedin Y, Monpouet S, Guignot J, Servin AL, Matthews S, Moseley SL.

J Biol Chem. 2006 Sep 29;281(39):29120-30. Epub 2006 Aug 1.

48.

Interferometric polarization control.

Chuss DT, Wollack EJ, Moseley SH, Novak G.

Appl Opt. 2006 Jul 20;45(21):5107-17.

PMID:
16826249
49.

Expression of putative virulence factors of Escherichia coli O157:H7 differs in bovine and human infections.

Rashid RA, Tabata TA, Oatley MJ, Besser TE, Tarr PI, Moseley SL.

Infect Immun. 2006 Jul;74(7):4142-8.

50.

Crystal structure and mutational analysis of the DaaE adhesin of Escherichia coli.

Korotkova N, Le Trong I, Samudrala R, Korotkov K, Van Loy CP, Bui AL, Moseley SL, Stenkamp RE.

J Biol Chem. 2006 Aug 4;281(31):22367-77. Epub 2006 Jun 2.

Supplemental Content

Loading ...
Support Center